Acknowledgements
The authors gratefully acknowledge U. Schulze, A. Farber and V. Panier for their expert reflections on this topic. The authors would also like to thank T. Guez, F. Bellino and M. Fuller for the support on the research and assembly of the report.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors of this article are or were employees of The Boston Consulting Group (BCG), a management consultancy that works with the world's leading biopharmaceutical companies. The research for this specific article was funded by BCG's Health Care practice.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Valencia, P., Richard, M., Brock, J. et al. The human microbiome: opportunity or hype?. Nat Rev Drug Discov 16, 823–824 (2017). https://doi.org/10.1038/nrd.2017.154
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2017.154
- Springer Nature Limited
This article is cited by
-
Natural products in drug discovery: advances and opportunities
Nature Reviews Drug Discovery (2021)
-
Microbiota: a novel regulator of pain
Journal of Neural Transmission (2020)